The largest database of trusted experimental protocols

Peptidomimetics

Peptidomimetics are a class of synthetic compounds designed to mimic the biological activity of natural peptides.
These molecules are engineered to overcome the limitations of natural peptides, such as poor stability, low bioavailability, and rapid degradation.
Peptidomimetics are used in a variety of applications, including drug development, biochemical research, and therapeutic interventions.
They can be designed to target specific receptors, enzymes, or signaling pathways, allowing for the development of highly selective and potent therapeutic agents.
The study of peptidomimetics is an active area of research, with ongoing efforts to optimize their structure, function, and pharmacokinetic properties.
This MeSH term provides a concise overview of this important class of synthetic compounds and their relevance in biomedial research and clinical applications.

Most cited protocols related to «Peptidomimetics»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Aequorin agonists Amino Acids antagonists beta-Arrestins Biological Assay Biopharmaceuticals Chinese Hamster Cloning Vectors Discrimination, Psychology DNA Replication Hyposensitization Therapies Ligands Luminescence Ovary Peptides Peptidomimetics polypeptide C
Assays were performed as previously described.21 (link),22 (link),31 (link),37 (link),39 (link),40 (link) Briefly, HEK-293 cells (~4.5 × 105 per 24-well plates-mm dish) were transiently cotransfected with pairs of plasmids or single plasmids using Lipofectamine 2000 (Invitrogen). At 24 h after transfection with CLuc-FGF14 or CD4-Nav1.6-NLuc (or other indicated plasmids), cells were detached from the 24-well plate using a 0.04% trypsin:EDTA mixture dissolved in PBS. Cell suspension was centrifuged for 5 min at 6000 rmp and seeded in white, clear-bottom 96-well tissue culture plates (Greiner Bio-One) in 200 μL of medium. The cells were incubated for another 24 h, and then the growth medium was replaced with 100 μL of serum-free, phenol red-free DMEM/F-12 medium (Invitrogen). Peptidomimetics were dissolved in DMSO, and were added to a final concentration of 1–500 μM in the serum-free medium and cells were incubated with peptidomimetics for 1 h. The final concentration of DMSO was maintained at 0.5%. The bioluminescence reaction was initiated by automatic injection of 100 μL of d-luciferin substrate (1.5 mg/mL dissolved in PBS) using a Synergy H4 multimode microplate reader (BioTek, Winooski, VT). Luminescence readings were initiated after 3 s of mild plate shaking and performed at 2 min intervals for 20 min with integration times of 0.5 s. Raw signal intensity was computed by averaging peak luminescence plus two adjacent time points. Normalized signal intensity was expressed as percentage of mean signal intensity relative to control treated with 0.5% DMSO. Full-length Photinus luciferase activity was determined by transfecting HEK293 cells, as above, with pGL3 firefly luciferase plasmid, as described previously.39 (link) Cells were maintained at 37 °C throughout the measurements. Additional information for LCA can be found in a dedicated book chapter.51 (link)
Publication 2018
Biological Assay Cells Edetic Acid FGF14 protein, human HEK293 Cells Hyperostosis, Diffuse Idiopathic Skeletal lipofectamine 2000 luciferase, Photinus Luciferases, Firefly Luciferins Luminescence Paragangliomas 3 Peptidomimetics Plasmids Serum Sulfoxide, Dimethyl Tissues Transfection Trypsin
MIC was determined by using the micro-dilution method according to guidelines of the Clinical and Laboratory Standards Institute [57] . Peptidomimetic 1 and erythromycin 1∶2 serial dilutions were prepared from 1024 µg/mL stock solutions to give a final range of 512-0.5 µg/mL in the wells. Ampicillin 1∶2 serial dilutions were prepared from a 256 µg/mL stock solution to give a final range of 128-0.13 µg/mL in the wells. Polymyxin B and gentamicin 1∶2 serial dilutions were prepared from a 64 µg/mL stock solution to give a final range of 32-0.03 µg/mL in the wells. Also, 1∶2 serial dilutions of the AMPs KR-12, IsCTp, melittin and PEP-1-K were prepared from 64 µg/mL stock solutions to give a final range of 32-0.03 µg/mL in the wells; however this was performed in 1% peptone instead of in MHB since activity was drastically diminished in the latter (not shown).
The population lineages were tested for their susceptibility towards peptidomimetic 1, polymyxin B, gentamicin and ampicillin. Single-culture isolates selected from these populations were additionally tested against peptidomimetic 1, polymyxin B, erythromycin and the five reference AMPs. To estimate the level of cross-resistance to closely related peptidomimetics, MIC determinations were performed for peptidomimetics 2 and 3 (Figure 1) towards selected isolates. The bacterial suspensions were grown overnight in MHB at 37°C for determination of the population MIC, or individual isolates were grown overnight on non-selective BHI agar at 37°C. MIC determination performed on the wild-type strain using re-suspended colonies, as well as on a culture grown overnight in broth, showed that pre-growth in broth had minimal effect on the MIC results. In order to determine the population MIC, the respective compound (peptidomimetic 1 or polymyxin B) was added to give a concentration corresponding to 32×MIC to maintain the selection pressure of the freezer-revived lineages, and then MIC determination was performed on the outgrown population (i.e. ∼109 CFU/mL). In all experiments, bacterial cells were suspended in 0.9% saline to give a turbidity of 0.13 at OD546 (approximately 1×108 CFU/mL) and diluted in MHB pH 7.4 to a final concentration of 5×105 CFU/mL in each well. Polypropylene plates (Nunc 442587) were used to minimize peptide binding, and the incubation time was 18–20 hours at 37°C. Incubation time was additionally extended up to 44 hours for the individual isolates due to a potential effect of growth rate on the outcome, but no effect was seen of this (not shown). MIC was found in a minimum of two technical (population MIC) or biological (isolate MIC) replicates as the lowest concentration of the AMP or antibiotic where no visible growth was observed.
Full text: Click here
Publication 2013
Agar Ampicillin Antibiotics Bacteria Biopharmaceuticals Cells Clinical Laboratory Techniques Erythromycin Gentamicin I 109 Melitten ML 1024 Normal Saline Peptides Peptidomimetics Peptones Polymyxin B Polypropylenes Pressure Strains Susceptibility, Disease Technique, Dilution Vision
The peptidomimetic Melimine (TLISWIKNKRKQRPRVSRRRRRRGGRRRR) is a chimera of the naturally occurring peptides melittin (GIGAVLKVLTTGLPALISWIKRKRQQ) and protamine (MPRRRRSSSRPVRRR-RRPRVSRRRRRRGGRRRR) [55 (link)]. A derivative of Melimine, Mel4 (KNKRKRRRRRRGGRRRR) was developed for improved biocompatibility [39 (link)]. These peptides were purchased from AusPep Peptide Company (Tullamarine, VIC, Australia). The purity of the purchased peptides was ≥90%. The peptidomimetic compound RK758 used in this study was synthesised according to the patents (WO2018081869A1 and Australian Provisional Patent Application No. 2021902457.), and its chemical structure is available in the Supplementary File.
Full text: Click here
Publication 2022
Chimera melimine Melitten Peptides Peptidomimetics Protamines
The X-ray crystal structures of Mpro (7BQY) and PLpro (6WX4) in complex with potent covalent peptidomimetic inhibitors were downloaded from the Protein Data Bank. Both proteins were prepared using the Protein Preparation Wizard in Maestro (Schrödinger Release 2019-3, https://www.Schrodinger.Com), waters, and other co-crystallized molecules were removed, except for the ligand. Predicting protonation states of protein residues were calculated, considering a temperature of 300 °K and a pH of 7. The ligands were prepared using the Ligprep tool considering the ionization states at pH 7 ± 2. A 15 Å docking grid (inner-box 10 Å and outer-box 20 Å) was prepared using as centroid the co-crystallized ligand. The docking studies were performed using Glide SP precision, keeping the default parameters and setting, and it was combined with “molecular mechanics generalized Born surface area” (MMGBSA), implemented in the Prime module from Maestro to re-score the three-output docking poses of each compound. In the case of compound MG-101, a further analysis was performed using Covalent docking simulations implemented in Maestro (Covalent Dock Lead Optimization workflow) and the best poses were rescored with MMGBSA. Molecular Operating Environment 2019.1 (MOE) was used to visualize the structures and acquire the images.
Full text: Click here
Publication 2022
A 300 Childbirth inhibitors Ligands Mechanics Peptidomimetics Proteins Radiography Rumex

Most recents protocols related to «Peptidomimetics»

Not available on PMC !

Example 6

Anti-Norovirus Activity

Norwalk virus replicon assays were performed as reported by Constantini et al. (Antivir Ther 2012, 17, 981-991). HG23 cells (derived from Huh-7 cells) containing NoV replicon RNA are seeded at a density of 3,000 cells/well in 96-well plates and incubated at 37° C. and 5% CO2 overnight. Compounds were tested at concentrations ranging from 0.1 to 100 μM. Compounds were added in triplicate to 80 to 90% confluent monolayers and incubated at 37° C. and 5% CO2. Untreated cells were included in each plate. Following five days incubation (37° C., 5% CO2), total cellular RNA was isolated with RNeasy96 extraction kit from Qiagen. Replicon RNA and an internal control (TaqMan rRNA control reagents, Applied Biosystems) were amplified in a single step.

The median effective concentrations (EC50) ranges of several of the compounds described herein against NoV are shown in Table 3:

TABLE 3
Anti-NoV activity (μM)
CompoundEC50EC90
110.72.4
190.070.27
230.070.33
290.080.46
674.33>20
830.330.91
84>10ND

Full text: Click here
Patent 2024
Biological Assay Cells Norovirus Norwalk virus Peptidomimetics Replicon Ribosomal RNA

Example 12

The ability of these compounds to inhibit the NoV, specifically Minerva virus protease catalytic Cys139 covalently (IC50 and Ki) was determined with an enzyme kinetic assay. NoV strains, specifically GII.4 such as the Minerva virus are responsible for causing the majority (˜80%) of infections in humans. The activity of the inhibitors was evaluated by monitoring the cleavage of a FRET substrate every one minute for 20 minutes (excitation/emission: 488/520 nm) using a SpectraMax M5 microplate reader (Molecular Devices, Sunnyvale CA). Serial dilutions of each inhibitor were incubated with enzyme for 90 minutes at 37° C. before addition of the FRET substrate to ensure complete inactivation. Commercially available protease inhibitors chymostatin and rupintrivir were used as controls.

TABLE 4
CompoundIC50 (μM)Ki (μM)
110.112 ± 0.0250.427 ± 0.109
190.150 ± 0.002 1.19 ± 0.444
230.204 ± 0.009 1.59 ± 0.050
290.140 ± 0.0170.670 ± 0.019
350.167 ± 0.0050.858 ± 0.032
36 1.17 ± 0.333 3.60 ± 0.501
372.63 ± 1.0414.03 ± 5.55 
38>10ND
39>10ND
64>100ND
6730.0 ± 1.8 >100
830.482 ± 0.07 7.095 ± 5.583
84>100ND
chymostatin13.71.6 ± 1.0
rupintrivir23.68.2 ± 2.3

Full text: Click here
Patent 2024
Cardiac Arrest Catalysis chymostatin Cytokinesis Enzyme Assays Enzymes Fluorescence Resonance Energy Transfer Homo sapiens Infection inhibitors Kinetics Medical Devices Norovirus Infection Peptide Hydrolases Peptidomimetics Protease Inhibitors rupintrivir Strains Technique, Dilution Virus

Example 4

Mitochondrial Toxicity Assays in Neuro2A Cells

To estimate the potential of the compounds of this invention to cause neuronal toxicity, mouse Neuro2A Cells (American Type Culture Collection 131) can be used as a model system (see Ray A S, Hernandez-Santiago B I, Mathew J S, Murakami E, Bozeman C, Xie M Y, Dutschman G E, Gullen E, Yang Z, Hurwitz S, Cheng Y C, Chu C K, McClure H, Schinazi R F, Anderson K S. Mechanism of anti-human immunodeficiency virus activity of beta-D-6-cyclopropylamino-2′,3′-didehydro-2′,3′-dideoxyguanosine. Antimicrob. Agents Chemother. 2005, 49, 1994-2001). The concentrations necessary to inhibit cell growth by 50% (CCso) can be measured using the 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide dye-based assay, as described. Perturbations in cellular lactic acid and mitochondrial DNA levels at defined concentrations of drug can be carried out as described above. ddC and AZT can be used as control nucleoside analogs.

Full text: Click here
Patent 2024
Biological Assay Biological Models Bromides Cardiac Arrest Cells DNA, Mitochondrial Drug Kinetics HIV Lactic Acid Mitochondrial Inheritance Mus Neurons Norovirus Infection Nucleoside Analogs Peptidomimetics Pharmaceutical Preparations
Peptide Ala-Thr-Trp-Leu-Pro-Pro-Arg (A7R) and peptidomimetic Lys(hArg)-Dab-Pro-Arg (K4R) as well as their conjugates with Ahx linker and DOTA chelator (DOTA-Ahx-A7R—conjugate 1, and DOTA-Ahx-K4R—conjugate 2) were synthesized manually by SPPS method on the preloaded Fmoc-Arg(Pbf)-Wang resin following the Fmoc chemistry with DIC/HOBt coupling method and active ester method for coupling DOTA-tris(tBu)-NHS [41 (link)]. In the case of conjugate 1 (DOTA-Ahx-A7R), a linear chain was built first, and then without cleavage peptide from the resin, the linker and chelator were attached to the N-terminus of the alanine residue (Path I in Scheme 1). Additionally, in the case of conjugate 2 (DOTA-Ahx-K4R containing branched K4R peptidomimetic) synthesis, the main linear chain was first built, and next it was extended by two branches: first at the N-terminus by adding lysine residue (as a Boc-Lys(Fmoc) building block), which was then guanylated after deprotection of the Fmoc group, and second in the 2,4-diaminobutyric acid (Dab) side chain, where Fmoc-Ahx-OH and DOTA-tris(tBu)-NHS ester were added (Path II in Scheme 1). All detailed information is thoroughly described in our previous publication [41 (link)]. Retaining the N-terminal fragment of Lys(hArg) unchanged was necessary to maintain high affinity binding to the NRP-1 co-receptor, according to data obtained in [38 (link)].
Full text: Click here
Publication 2023
1-hydroxybenzotriazole Acids Ala-Thr-Trp-Leu-Pro-Pro-Arg Alanine Anabolism Chelating Agents Cytokinesis Esters Peptides Peptidomimetics prolylarginine Resins, Plant stable plasma protein solution tetraxetan Tromethamine Wang resin

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Amides Cells Chinese fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether Ligands Peptidomimetics Proteins SARS-CoV-2

Top products related to «Peptidomimetics»

Sourced in United States
Neuro-2a cells are a mouse neuroblastoma cell line derived from a spontaneous tumor. They are commonly used as a model for studying neurological processes and function.
Fmoc Rink amide is a solid-phase synthesis resin used for the preparation of C-terminal amidated peptides. It is compatible with standard Fmoc-based peptide synthesis protocols.
Sourced in United States
2-chlorotrityl chloride resin is a solid-phase synthesis reagent used in organic chemistry. It is a chloromethylated polystyrene-based resin that is commonly used for the immobilization and purification of organic compounds. The resin provides a convenient platform for the attachment and subsequent manipulation of molecules during various synthetic steps.
Sourced in United States
Radiolabeled compounds are chemical substances that have been tagged with radioactive isotopes. These compounds are used in various scientific and medical applications, including research, diagnostic imaging, and therapeutic procedures. The core function of radiolabeled compounds is to serve as tracers, allowing researchers and clinicians to monitor and study biochemical processes or to target specific cells or tissues within the body.
Sourced in United States
The Harvester is a specialized laboratory equipment designed for the collection and harvesting of biological samples. It functions as a precise and efficient tool for the extraction and separation of cellular components, tissues, or other biological materials from a sample. The Harvester operates through a controlled and automated process, ensuring consistent and reliable results.
Sourced in United States
AutoDock Tools 1.5.6 is a molecular docking software package. It allows users to perform automated docking of ligands (small molecules) to protein receptors. The software provides a graphical user interface for preparing input files, running docking calculations, and analyzing the results.
Sourced in United States, China, Japan, Switzerland, United Kingdom, Canada, Germany, Brazil, Uruguay
The SpectraMax M5 is a multi-mode microplate reader designed for absorbance, fluorescence, and luminescence measurements. It provides a diverse range of capabilities to support various applications in life science research and drug discovery.
Sourced in United States
The Wallac 1450 MicroBeta is a versatile liquid scintillation counter designed for high-throughput radioactivity detection. It offers automated sample handling and provides precise quantification of radioactive samples.
Sourced in United States, Germany
Batimastat is a laboratory product manufactured by Merck Group. It is a synthetic matrix metalloproteinase inhibitor. Its core function is to inhibit the activity of matrix metalloproteinases, which are enzymes involved in the breakdown of extracellular matrix components.
The TaqMan rRNA control reagents are a set of tools designed to monitor the performance of real-time PCR assays. These reagents target specific ribosomal RNA (rRNA) sequences and can be used to assess the efficiency and consistency of the RNA extraction, reverse transcription, and amplification steps in gene expression studies.

More about "Peptidomimetics"

Peptidomimetics: Unlocking the Potential of Synthetic Peptides Peptidomimetics are a class of synthetic compounds designed to mimic the biological activity of natural peptides.
These innovative molecules are engineered to overcome the limitations of their natural counterparts, such as poor stability, low bioavailability, and rapid degradation.
Peptidomimetics have become a crucial focus in biomedical research and drug development, offering a wealth of possibilities in therapeutic interventions.
As researchers delve into the world of peptidomimetics, they often utilize a variety of techniques and tools to explore their potential.
Neuro-2a cells, for instance, have been employed as a model system to study the cellular effects of these synthetic peptides.
Fmoc Rink amide and 2-chlorotrityl chloride resin are common solid-phase peptide synthesis resins used to construct peptidomimetic structures.
Radiolabeled compounds can be employed to track the pharmacokinetic behavior of these molecules, while specialized equipment like the Harvester, AutoDock Tools 1.5.6, SpectraMax M5, and Wallac 1450 MicroBeta help scientists analyze and optimize their properties.
In the pursuit of therapeutic applications, peptidomimetics have shown promise in areas like Batimastat, a synthetic matrix metalloproteinase inhibitor with potential anti-cancer and anti-inflammatory effects.
Researchers continue to explore the versatility of peptidomimetics, leveraging advanced techniques and tools to unlock their full potential.
As the field of peptidomimetics continues to evolve, researchers rely on platforms like PubCompare.ai to streamline their literature searches and identify the most effective protocols.
By harnessing the power of artificial intelligence, these tools enable scientists to navigate the vast landscape of research, optimizing their peptidomimetics studies and driving innovative breakthroughs.